Published in Antimicrob Agents Chemother on March 01, 1990
beta-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev (1995) 12.53
blaI and blaR1 regulate beta-lactamase and PBP 2a production in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1993) 1.86
Characterization of mechanisms of resistance to beta-lactam antibiotics in methicillin-resistant strains of Staphylococcus saprophyticus. Antimicrob Agents Chemother (1990) 1.41
Characterization of four beta-lactamases produced by Staphylococcus aureus. Antimicrob Agents Chemother (1992) 1.41
Borderline susceptibility to antistaphylococcal penicillins is not conferred exclusively by the hyperproduction of beta-lactamase. Antimicrob Agents Chemother (1991) 1.36
Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure. Antimicrob Agents Chemother (2009) 1.35
Nucleotide sequence of the beta-lactamase gene from Enterococcus faecalis HH22 and its similarity to staphylococcal beta-lactamase genes. Antimicrob Agents Chemother (1991) 1.22
Characterization of a chromosomal gene encoding type B beta-lactamase in phage group II isolates of Staphylococcus aureus. Antimicrob Agents Chemother (1998) 1.16
Recombinant expression and characterization of the major beta-lactamase of Mycobacterium tuberculosis. Antimicrob Agents Chemother (1998) 1.12
In vivo effect of cefazolin, daptomycin, and nafcillin in experimental endocarditis with a methicillin-susceptible Staphylococcus aureus strain showing an inoculum effect against cefazolin. Antimicrob Agents Chemother (2013) 1.00
Comparison of the beta-lactamase gene cluster in clonally distinct strains of Enterococcus faecalis. Antimicrob Agents Chemother (1996) 0.97
Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother (2012) 0.97
RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal beta-lactamases. Antimicrob Agents Chemother (2003) 0.96
Structure-function relationships among wild-type variants of Staphylococcus aureus beta-lactamase: importance of amino acids 128 and 216. J Bacteriol (1996) 0.95
Purification of Staphylococcus aureus beta-lactamases by using sequential cation-exchange and affinity chromatography. Antimicrob Agents Chemother (1990) 0.92
Association of borderline oxacillin-susceptible strains of Staphylococcus aureus with surgical wound infections. J Clin Microbiol (1998) 0.92
Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother (2010) 0.90
Efficacy of prophylaxis with beta-lactams and beta-lactam-beta-lactamase inhibitor combinations against wound infection by methicillin-resistant and borderline-susceptible Staphylococcus aureus in a guinea pig model. Antimicrob Agents Chemother (1993) 0.88
Antistaphylococcal activity of TD-1792, a multivalent glycopeptide-cephalosporin antibiotic. Antimicrob Agents Chemother (2011) 0.83
Prevalence of blaZ gene types and the cefazolin inoculum effect among methicillin-susceptible Staphylococcus aureus blood isolates and their association with multilocus sequence types and clinical outcome. Eur J Clin Microbiol Infect Dis (2014) 0.83
beta-Lactamase-mediated inactivation and efficacy of cefazolin and cefmetazole in Staphylococcus aureus abscesses. Antimicrob Agents Chemother (1993) 0.82
Association between type A blaZ Gene Polymorphism and Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus. Antimicrob Agents Chemother (2016) 0.75
Production of A and C variants of staphylococcal beta-lactamase by methicillin-resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother (1994) 0.75
Efficacy of Ceftaroline in a Rat Model of Endocarditis Against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High Inoculum Effect. Antimicrob Agents Chemother (2017) 0.75
Characteristics of cefazolin inoculum effect-positive methicillin-susceptible staphylococcus aureus infection in a multicentre bacteraemia cohort. Eur J Clin Microbiol Infect Dis (2016) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother (1972) 61.10
Staphylococcal penicillinase and the new penicillins. Biochem J (1962) 9.04
WILD-TYPE VARIANTS OF EXOPENICILLINASE FROM STAPHYLOCOCCUS AUREUS. Biochem J (1965) 3.79
Membrane-bound penicillinases in Gram-positive bacteria. J Biol Chem (1982) 2.69
Penicillinase plasmids of Staphylococcus aureus: structural and evolutionary relationships. Plasmid (1980) 2.25
STUDIES ON PENICILLINASE PRODUCED BY A STRAIN OF STAPHYLOCOCCUS AUREUS. Proc R Soc Lond B Biol Sci (1963) 2.24
Differentiation of beta-lactamase variants of Staphylococcus aureus by substrate hydrolysis profiles. J Infect Dis (1989) 1.80
An unusual "penicillinase plasmid" in staphylococcus aureus; evidence for its transfer under natural conditions. J Med Microbiol (1974) 1.28
Naturally occurring constitutive -lactamase of novel serotype in Staphylococcus aureus. J Gen Microbiol (1973) 1.21
Penicillinase production in Staphylococcus aureus strains of clinical importance. Dan Med Bull (1986) 1.05
Localisation of the penicillinase gene in naturally occurring Staphylococcus aureus strains. Acta Pathol Microbiol Immunol Scand B (1985) 0.99
Evaluation of cefotaxime alone and in combination with desacetylcefotaxime against strains of Staphylococcus aureus that produce variants of staphylococcal beta-lactamase. Diagn Microbiol Infect Dis (1989) 0.90
Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol (1999) 5.83
Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests. J Infect Dis (1977) 4.00
Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent. J Infect Dis (1977) 3.15
CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens. Neurology (2001) 2.88
Aminoglycoside therapy of gram-negative bacillary meningitis. N Engl J Med (1975) 2.64
Seroepidemiology and chemoprophylaxis disease due to sulfonamide-resistant Neisseria meningitidis in a civillian population. J Infect Dis (1974) 2.64
Controlled evaluation of BACTEC Plus 26 and Roche Septi-Chek aerobic blood culture bottles. J Clin Microbiol (1991) 2.62
Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum. Antimicrob Agents Chemother (1981) 2.04
Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis. Am J Med (1978) 2.04
Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol (1993) 2.00
Controlled evaluation of the agar-slide and radiometric blood culture systems for the detection of bacteremia and fungemia. J Clin Microbiol (1986) 1.98
Antibiotic prophylaxis in vascular surgery. Ann Surg (1978) 1.97
Antimicrobial prophylaxis in surgery. N Engl J Med (1986) 1.97
Controlled evaluation of BACTEC PLUS 27 and Roche Septi-Chek anaerobic blood culture bottles. J Clin Microbiol (1992) 1.92
Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis. Am J Med (1985) 1.92
Sporadic cases of Legionnaires' disease: the expanding clinical spectrum. Ann Intern Med (1979) 1.85
Differentiation of beta-lactamase variants of Staphylococcus aureus by substrate hydrolysis profiles. J Infect Dis (1989) 1.80
Correlation of serum bactericidal activity with antimicrobial agent level and minimal bactericidal concentration. J Infect Dis (1982) 1.74
Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis (1983) 1.72
Comparison of the Staph-Ident system with a conventional method for species identification of urine and blood isolates of coagulase-negative staphylococci. J Clin Microbiol (1983) 1.66
Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents. J Infect Dis (1996) 1.63
Intracoronary thrombolysis in patients with acute myocardial infarction: comparison of the efficacy of urokinase with streptokinase. Circulation (1984) 1.43
Characterization of four beta-lactamases produced by Staphylococcus aureus. Antimicrob Agents Chemother (1992) 1.41
Selecting cost-effective antimicrobial prophylaxis in surgery: are we getting what we pay for? DICP (1990) 1.41
Thermonuclease test for same-day identification of Staphylococcus aureus in blood cultures. J Clin Microbiol (1985) 1.40
The expanding horizons of infection control. Infect Control Hosp Epidemiol (1995) 1.39
Cefoxitin versus erythromycin, neomycin, and cefazolin in colorectal operations. Importance of the duration of the surgical procedure. Ann Surg (1983) 1.38
Bronchopulmonary cross-colonization and infection related to mycobacterial contamination of suction valves of bronchoscopes. J Infect Dis (1989) 1.26
Guidelines for infection control in intravenous therapy. Ann Intern Med (1973) 1.24
Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies. Antimicrob Agents Chemother (1987) 1.23
Low-level colonization of hospitalized patients with methicillin-resistant coagulase-negative staphylococci and emergence of the organisms during surgical antimicrobial prophylaxis. Antimicrob Agents Chemother (1988) 1.23
Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis. Clin Infect Dis (1996) 1.22
RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci. Diagn Microbiol Infect Dis (1993) 1.20
Prospectus: the prevention of bacteremic pneumococcal pneumonia. A conservative appraisal of vaccine intervention. JAMA (1974) 1.20
In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 1.19
Failure of cephalosporins to prevent Staphylococcus aureus surgical wound infections. JAMA (1990) 1.15
Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis. Am J Med (1987) 1.10
Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1992) 1.09
Candidal suppurative peripheral thrombophlebitis. Ann Intern Med (1982) 1.08
Sensitivity, specificity, and predictive value of body surface cultures in a neonatal intensive care unit. JAMA (1988) 1.08
Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus pneumoniae. Clin Infect Dis (1995) 1.06
Endemic staphylococcal pseudobacteremia. Infect Control (1981) 1.06
Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1985) 1.03
Tularemia and rhabdomyolysis. JAMA (1985) 1.02
Growth of Staphylococcus aureus with nafcillin in vitro induces alpha-toxin production and increases the lethal activity of sterile broth filtrates in a murine model. J Infect Dis (1995) 1.01
Factors affecting growth and susceptibility testing of Helicobacter pylori in liquid media. J Clin Microbiol (1995) 1.00
Tuberculoid tenosynovitis and carpal tunnel syndrome caused by Mycobacterium szulgai. Am J Med (1978) 0.99
The pharmacokinetics and efficacy of an aminoglycoside administered into the cerebral ventricles in neonates: implications for further evaluation of this route of therapy in meningitis. J Infect Dis (1981) 0.98
Localized brucellosis: popliteal artery aneurysm, mediastinitis, dementia, and pneumonia. Rev Infect Dis (1989) 0.97
Epidemiological spectrum and current treatment of listeriosis. Rev Infect Dis (1992) 0.97
Prophylactic anti-infective activity of poly-[1-6]-beta-D-glucopyranosyl-[1-3]-beta-D-glucopryanose glucan in a guinea pig model of staphylococcal wound infection. Antimicrob Agents Chemother (1998) 0.97
Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases. Antimicrob Agents Chemother (1995) 0.95
Comparative prophylactic efficacy of cefazolin and vancomycin in a guinea pig model of Staphylococcus aureus wound infection. J Infect Dis (1993) 0.95
Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Betafectin Gastrointestinal Study Group. Arch Surg (1999) 0.95
Pyomyositis: tropical disease in a temperate climate. Am J Med (1981) 0.94
Evaluation of new anti-infective drugs for surgical prophylaxis. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 0.94
Abbreviated surveillance of nosocomial urinary tract infections: a new approach. Infect Control (1985) 0.93
Controlled evaluation of modified radiometric blood culture medium supplemented with gelatin for detection of bacteremia and fungemia. J Clin Microbiol (1987) 0.93
Purification of Staphylococcus aureus beta-lactamases by using sequential cation-exchange and affinity chromatography. Antimicrob Agents Chemother (1990) 0.92
Association of borderline oxacillin-susceptible strains of Staphylococcus aureus with surgical wound infections. J Clin Microbiol (1998) 0.92
Comparison of kill-kinetic studies with agar and broth microdilution methods for determination of antimicrobial activity of selected agents against members of the Bacteroides fragilis group. J Clin Microbiol (1987) 0.92
Comparative prophylactic efficacies of ciprofloxacin, ofloxacin, cefazolin, and vancomycin in experimental model of staphylococcal wound infection. Antimicrob Agents Chemother (1994) 0.91
Medical management of visceral actinomycosis. South Med J (1983) 0.91
Localization of gonococcal lipopolysaccharide and its relationship to toxic damage in human fallopian tube mucosa. Infect Immun (1986) 0.91
Rapid diagnosis of Candida sepsis in surgical patients. Am Surg (1987) 0.91
Hemophilus influenzae pneumonia in adults: report of five cases caused by ampicillin-resistant strains. Am Rev Respir Dis (1980) 0.90
Synergistic resistance mechanisms in Pseudomonas aeruginosa. J Antimicrob Chemother (1987) 0.89
Comparison of the effect of refrigerated versus room temperature media on the isolation of Neisseria gonorrhoeae from genital specimens. J Clin Microbiol (1985) 0.89
Efficacy of prophylaxis with beta-lactams and beta-lactam-beta-lactamase inhibitor combinations against wound infection by methicillin-resistant and borderline-susceptible Staphylococcus aureus in a guinea pig model. Antimicrob Agents Chemother (1993) 0.88
Use of time-kill methodology to assess antimicrobial combinations against metronidazole-susceptible and metronidazole-resistant strains of Helicobacter pylori. Antimicrob Agents Chemother (1995) 0.87
Endocarditis due to Veillonella alcalescens. South Med J (1984) 0.86
Candidal meningitis following bacterial meningitis. South Med J (1990) 0.86
Falsely elevated serum creatinine levels secondary to the presence of 5-fluorocytosine. Am J Clin Pathol (1985) 0.85
Torulopsis glabrata endocarditis. JAMA (1980) 0.84
In-vitro evaluation of nitrofurantoin as an alternative agent for metronidazole in combination antimicrobial therapy against Helicobacter pylori. J Antimicrob Chemother (1998) 0.84
Immunogenicity of the intradermal route of hepatitis B vaccination with the use of recombinant hepatitis B vaccine. Am J Infect Control (1989) 0.84
The formulary: an educational tool for clinical pharmacology. Clin Pharmacol Ther (1992) 0.84
Granulomatous tenosynovitis and carpal tunnel syndrome caused by Sporothrix schenckii. Am J Med (1981) 0.83
Effect of chemical treatment on electrical conductivity, infrared absorption, and Raman spectra of single-walled carbon nanotubes. J Phys Chem B (2005) 0.82
Regulation by IFN-beta of inducible nitric oxide synthase and interleukin-12/p40 in murine macrophages cultured in the presence of Chlamydia pneumoniae antigens. J Interferon Cytokine Res (2001) 0.82
Evaluation of spot CAMP test for identification of group B streptococci. J Clin Microbiol (1986) 0.81
Lethal toothache: parapharyngeal cellulitis complicating dental infection. South Med J (1979) 0.81
Susceptibility testing revisited. Prog Clin Pathol (1984) 0.81
Intrinsic methicillin resistance and phage complex 94/96 of Staphylococcus aureus. J Infect Dis (1988) 0.81
Brain abscess: association with pulmonary arteriovenous fistula and hereditary hemorrhagic telangiectasia: report of three cases. Am J Med (1988) 0.80
Cefamandole versus cefazolin in vascular surgical wound infection prophylaxis: cost-effectiveness and risk factors. J Vasc Surg (1993) 0.80
Vancomycin entry into lung lymph in sheep. Antimicrob Agents Chemother (1987) 0.80
High-level aminoglycoside-resistant enterococcus causing endocarditis successfully treated with a combination of ampicillin, imipenem and vancomycin. Scand J Infect Dis (1997) 0.80
Effective and creative surveillance and reporting of surgical wound infections. Infect Control (1982) 0.79
Assessment of the bactericidal activity of sparfloxacin, ofloxacin, levofloxacin, and other fluoroquinolones compared with selected agents of proven efficacy against Listeria monocytogenes. Diagn Microbiol Infect Dis (1994) 0.79
Effect of clavulanic acid on the activity of ticarcillin against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1986) 0.79
Bacterial pneumonias--an overview with emphasis on pathogenesis, diagnosis, and treatment. Heart Lung (1986) 0.79
Purpura fulminans in pneumococcal sepsis: case report and review. Scand J Infect Dis (1997) 0.79
Chlamydia pneumoniae and chronic skin wounds: a focused review. J Investig Dermatol Symp Proc (2001) 0.78
Intraventricular gentamicin in meningitis. Lancet (1980) 0.78
The usefulness of the serum bactericidal test in orthopedic infections. Orthopedics (1984) 0.78
Blastomyces dermatitidis and the adult respiratory distress syndrome. Case reports and review of the literature. Am Rev Respir Dis (1982) 0.78